1. Home
  2. EVI vs ANNX Comparison

EVI vs ANNX Comparison

Compare EVI & ANNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EVI Industries Inc.

EVI

EVI Industries Inc.

HOLD

Current Price

$19.91

Market Cap

353.9M

ML Signal

HOLD

Logo Annexon Inc.

ANNX

Annexon Inc.

HOLD

Current Price

$5.75

Market Cap

730.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVI
ANNX
Founded
1959
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
353.9M
730.4M
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
EVI
ANNX
Price
$19.91
$5.75
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
6
Target Price
$35.00
$16.50
AVG Volume (30 Days)
30.3K
2.2M
Earning Date
05-21-2026
01-01-0001
Dividend Yield
1.73%
N/A
EPS Growth
32.43
42.94
EPS
0.26
N/A
Revenue
$389,830,000.00
N/A
Revenue This Year
$15.53
N/A
Revenue Next Year
$3.83
N/A
P/E Ratio
$73.19
N/A
Revenue Growth
10.26
N/A
52 Week Low
$14.99
$1.29
52 Week High
$34.82
$7.18

Technical Indicators

Market Signals
Indicator
EVI
ANNX
Relative Strength Index (RSI) 47.53 53.33
Support Level $18.23 $4.77
Resistance Level $21.01 $7.18
Average True Range (ATR) 1.14 0.36
MACD 0.17 0.06
Stochastic Oscillator 53.46 50.97

Price Performance

Historical Comparison
EVI
ANNX

About EVI EVI Industries Inc.

EVI Industries Inc through its subsidiaries, is a distributor that sells, leases, and rents commercial, industrial, and vended laundry and dry cleaning equipment and steam and hot water boilers manufactured by others, supplies related replacement parts and accessories, designs and plans turn-key laundry, dry cleaning, and boiler systems, and provides installation and maintenance services to its customers, which include commercial, industrial, institutional, government, and retail customers. These activities are conducted in the United States, Canada, the Caribbean, and Latin America.

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.

Share on Social Networks: